|
|
| Wednesday October 7, 2020 |
| 1st MercachemSyncom eConference - DAY 1 |
|
| 16:00 | Opening & Introduction |
|
| Session Chair |
Dr Luc VAN HIJFTE
(MERCACHEMSYNCOM, Nijmegen, The Netherlands) |
| 16:10 | Transforming the Therapeutic Landscape with New Chemical Modalities (KL01) |
Dr Eric VALEUR
(FLAGSHIP VENTURELABS, Cambridge, United States) |
| 17:10 | Break |
|
| 17:20 | Enhancing Targeted Protein Degradation by Structure-Based PROTAC Design (IL01) |
Dr Siying ZHONG
(UNIVERSITY OF DUNDEE, Dundee, United Kingdom) |
| 17:55 | Targeting Non-Coding RNAs Using Synthetic Small Molecules: Scope and Applications (IL02) |
Dr Maria DUCA
(UNIVERSITY OF CÔTE D'AZUR, Nice, France) |
| 18:30 | Closing Remarks Day 1 |
|
| Thursday October 8, 2020 |
| 1st MercachemSyncom eConference - DAY 2 |
|
| 16:00 | Opening Remarks Day 2 |
|
| Session Chair |
Dr Peter MOLENVELD
(SYMERES, Nijmegen, The Netherlands) |
| 16:05 | Peptiligase Enzymes (IL03) |
Dr Leendert VAN DEN BOS
(ENZYTAG BV, Nuth, The Netherlands) |
| 16:40 | Activation of the Hippo Pathway via Targeting of Transcription Factor TEAD Using Designed Tertiary Protein Structure Mimetics (IL04) |
Dr Hélène ADIHOU
(ASTRAZENECA, Strasbourg, France) |
| 17:15 | Break |
|
| Session Chair |
Dr Ton VRIES
(MERCACHEMSYNCOM, Groningen, The Netherlands) |
| 17:25 | Click-Cleavable Antibody-Drug Conjugates (IL05) |
Dr Marc ROBILLARD
(TAGWORKS PHARMACEUTICALS, Eindhoven, The Netherlands) |
| 18:00 | Targeting the Tumor Microenvironment for Therapeutic and Diagnostic Purposes (IL06) |
Prof. Sebastien PAPOT
(SCT & UNIVERSITY OF POITIERS, Poitiers, France) |
| 18:35 | Closing Remarks & End of the eConference |
|
|
